Creating a better healthcare experience
Doctors in the U.S. write more than 4 billion prescriptions each year. PreCheck® MyScript helps make it easier, changing how physicians prescribe medicine.
Using PreCheck MyScript
EHR integration
Embedded into your existing workflow
When ePrescribing, PreCheck MyScript runs a trial claim and displays patient coverage, drug costs, and alternative medications
ePrescribing
No forms, faxes or calls to make
With PreCheck MyScript, there are no forms to fill out, and there’s no need to send us a fax or make a phone call.
Key benefits
Research found PCMS benefits patients, providers and pharmacies with lower costs, improved outcomes and reduced administrative burdens.
Save the patient money
When prescribers selected lower-cost alternative drugs suggested by PCMS, patients saved an average of $119 per prescription.1
Increase patient medication adherence
Patient medication adherence increased by up to 4% for 3 chronic conditions: diabetes, hypercholesterolemia and hypertension.2
Increase patient adoption
Patients whose providers used PCMS were more likely to obtain their medication than those whose providers did not use the tool.3
Provide pricing transparency and avoid PAs
Providers save 50 minutes and $41.05 per patient prescription each time an alternative is selected, avoiding prior authorizations.4
Getting the most out of your real-time benefits check tool data
Continue to ePrescribe. Review patient information presented. When appropriate, switch your patient to a lower-cost equivalent alternative.
Related healthcare insights
Article
Optum won the 2023 North American Enabling Technology Leadership Award.
Article
Discover an interactive EPCS mandate map providers can use to track where and when mandates are happening in each U.S. state.
Product information and resources
-
Download
PDF
Resource library
How to talk with patients about managing medication costs
While discussions about medication costs can be difficult, PCMS data gives providers access to patient-specific costs, coverage and therapeutic alternatives at point-of-care.
Sources
- Optum Rx analysis of full year (January–December 2023) trial claim and production claim data.
- Optum Rx data within the diabetes, statin, and hypertension therapeutic classes, 2016–2018.
- Internal Optum Rx study.
- Third-party analysis of Optum Rx claims data, July 2017–November 2018.